CLARITY Heads for a Senate Test | Ahead of the Curve
The CLARITY Act is approaching its first major Senate test, with a procedural vote scheduled for September 15. A revised 630-page draft is now on the table, but the central dispute over ethics provisions remains unresolved and Democratic support still appears lacking.
In this episode of Ahead of the Curve, we look at what the vote actually means, why failure would make passage in 2026 much harder, and how the U.S. regulatory landscape could still evolve through the SEC and CFTC even without legislation.
We also cover Hyperliquid’s intervention in the CME perpetual-futures lawsuit, Nasdaq’s $100 million investment in Kraken parent Payward, new research on the resources required for a potential future quantum attack, and Tether’s push into private credit through StableFund.
For more research and market insights, visit k33.com/research.
